PT2823427T - Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume - Google Patents

Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume

Info

Publication number
PT2823427T
PT2823427T PT137102497T PT13710249T PT2823427T PT 2823427 T PT2823427 T PT 2823427T PT 137102497 T PT137102497 T PT 137102497T PT 13710249 T PT13710249 T PT 13710249T PT 2823427 T PT2823427 T PT 2823427T
Authority
PT
Portugal
Prior art keywords
apparatuses
methods
prostate
predicting risk
gland volume
Prior art date
Application number
PT137102497T
Other languages
Portuguese (pt)
Original Assignee
Oy Arctic Partners Ab
Opko Diagnostics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oy Arctic Partners Ab, Opko Diagnostics Llc filed Critical Oy Arctic Partners Ab
Publication of PT2823427T publication Critical patent/PT2823427T/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96455—Kallikrein (3.4.21.34; 3.4.21.35)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Microbiology (AREA)
  • Software Systems (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Evolutionary Computation (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
PT137102497T 2012-03-05 2013-03-05 Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume PT2823427T (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261606554P 2012-03-05 2012-03-05
FI20125238 2012-03-05

Publications (1)

Publication Number Publication Date
PT2823427T true PT2823427T (en) 2021-03-22

Family

ID=65441575

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137102497T PT2823427T (en) 2012-03-05 2013-03-05 Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume

Country Status (8)

Country Link
JP (1) JP2020073885A (en)
KR (1) KR102303487B1 (en)
DE (1) DE202013012731U1 (en)
DK (1) DK2823427T3 (en)
ES (1) ES2859975T3 (en)
HK (1) HK1254684A1 (en)
HU (1) HUE054194T2 (en)
PT (1) PT2823427T (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240221957A1 (en) 2021-04-21 2024-07-04 Koichi Ito Information processing device for providing reference information relating to diagnosis of thyroid disease
US12100143B2 (en) * 2022-05-13 2024-09-24 City University Of Hong Kong Label-free liquid biopsy-based disease model, analytical platform and method for predicting disease prognosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101754812B (en) * 2007-05-04 2013-06-26 克拉洛诊断仪器公司 Fluidic connectors and microfluidic systems
AU2011239534B2 (en) * 2010-04-16 2015-01-22 Opko Diagnostics, Llc Feedback control in microfluidic systems

Also Published As

Publication number Publication date
DK2823427T3 (en) 2021-03-22
KR20200103872A (en) 2020-09-02
JP2020073885A (en) 2020-05-14
KR102303487B1 (en) 2021-09-16
ES2859975T3 (en) 2021-10-04
DE202013012731U1 (en) 2019-01-16
HK1254684A1 (en) 2019-07-26
HUE054194T2 (en) 2021-08-30

Similar Documents

Publication Publication Date Title
HK1206837A1 (en) Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume
IL254255B (en) Gene expression profile algorithm and test for determining prognosis of prostate cancer
HK1213771A1 (en) Methods of treating cancer
HK1206431A1 (en) Method for the prognosis and treatment of cancer metastasis
IL304337A (en) Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
EP2847593A4 (en) Methods for predicting and detecting cancer risk
SG10201703022SA (en) Method of prognosis and stratification of ovarian cancer
HK1259001A1 (en) Methods of prognosis and diagnosis of cancer
EP2867376A4 (en) Targeted rna-seq methods and materials for the diagnosis of prostate cancer
HK1220253A1 (en) Methods of detecting prostate cancer
ZA201604370B (en) Prostate cancer gene profiles and methods of using the same
IL232466A (en) Compositions and methods for prostate cancer analysis
HK1254684A1 (en) Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume
EP2932273A4 (en) Methods for diagnosing and treating prostate cancer
GB201202945D0 (en) Novel cancer therapies and methods